The effect of capsular extract of Morus Alba leaves on nephropathic complications of diabetes mellitus type 2
Phase 2
- Conditions
- Diabetic Nephropathy.Non-insulin-dependent diabetes mellitus with renal complications
- Registration Number
- IRCT2016021512438N18
- Lead Sponsor
- Barij Research Center of Medicinal Herbs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
inclusion criteria: patients 35 to 70 years old receiving reducer blood glucose drug and dietary recommendations for 3 to 5 years with type II diabetes. That LDL-cholesterol less than 130 and triglycerides less than 300.
Exclusion criteria: liver disease, allergies to plants used in the clinical trial, changing the dose of drug during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting plasma glucose. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Lipid profile. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Insulin. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Total anti oxidant capacity(TAC). Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Alanine aminotransferase(ALT), Aspartate aminotransferase(AST). Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Hs-CRP. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Blood urea nitrogen. Timepoint: Baseline and End-of-tria. Method of measurement: urine sample.;CREATININ. Timepoint: Baseline and End-of-tria. Method of measurement: urine sample.;PRO. Timepoint: Baseline and End-of-tria. Method of measurement: urine sample.;HbA1C. Timepoint: Baseline and End-of-tria. Method of measurement: percent of glycosylated hemoglobin.
- Secondary Outcome Measures
Name Time Method